Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Stebbing

Showing results (351-360 of 504) with videos related to

Pageof 51
Sort By:
Clinical Genitourinary Cancer|March 16, 2020
The Use of Transdermal Estrogen in Castrate-resistant, Steroid-refractory Prostate CancerKatherine Smith, Myria Galazi, Mark R Openshaw, et al.
Oncotargets and Therapy|June 3, 2021
Successful Treatment with Ensartinib After Alectinib-induced Hyperbilirubinemia in ALK-Positive NSCLCLing Peng, Kui Xiao, Jian Cui, et al.
Breast Cancer Research and Treatment|April 6, 2024
Circulating tumour DNA dynamics during alternating chemotherapy and hormonal therapy in metastatic breast cancer: the ALERT studyRebecca C Allsopp, Qi Guo, Karen Page, et al.
Biomarkers in Medicine|February 16, 2011
Circulating tumor cells and plasma DNA analysis in patients with indeterminate early or metastatic breast cancerJacqui A Shaw, James Brown, R Charles Coombes, et al.
Blood|July 9, 2004
Protease inhibitors potentiate chemotherapy-induced neutropeniaMark Bower, Neil McCall-Peat, Natalie Ryan, et al.
British Journal of Clinical Pharmacology|October 15, 2025
Beyond GLP-1s: The blueprint for systemic therapeutics that will reshape aging and medicineCarina C Kern, Annalisa Jenkins, D Nageshwar Reddy, et al.
The Journal of Antimicrobial Chemotherapy|December 21, 2004
A randomized study comparing a three- and four-drug HAART regimen in first-line therapy (QUAD study)Chloe Orkin, Justin Stebbing, Mark Nelson, et al.
Epigenomics|July 31, 2013
The p53 miRNA interactome and its potential role in the cancer clinicJonathan Krell, Adam E Frampton, Teresa Colombo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 11, 2009
Cryptogenic pseudocirrhosis: a new clinical syndrome of noncirrhotic portal hypertension (unassociated with advanced fibrosis) that can be detected by transient elastography in patients with HIVGeorge Panos, Lavanta Farouk, Justin Stebbing, et al.
JAMA Surgery|March 7, 2014
Reduced dissemination of circulating tumor cells with no-touch isolation surgical technique in patients with pancreatic cancerTamara M H Gall, Jimmy Jacob, Adam E Frampton, et al.
Pageof 51

Showing results (351-360 of 504) with videos related to

Sort By:
Pageof 51
Clinical Genitourinary Cancer|March 16, 2020
The Use of Transdermal Estrogen in Castrate-resistant, Steroid-refractory Prostate CancerKatherine Smith, Myria Galazi, Mark R Openshaw, et al.
Oncotargets and Therapy|June 3, 2021
Successful Treatment with Ensartinib After Alectinib-induced Hyperbilirubinemia in ALK-Positive NSCLCLing Peng, Kui Xiao, Jian Cui, et al.
Breast Cancer Research and Treatment|April 6, 2024
Circulating tumour DNA dynamics during alternating chemotherapy and hormonal therapy in metastatic breast cancer: the ALERT studyRebecca C Allsopp, Qi Guo, Karen Page, et al.
Biomarkers in Medicine|February 16, 2011
Circulating tumor cells and plasma DNA analysis in patients with indeterminate early or metastatic breast cancerJacqui A Shaw, James Brown, R Charles Coombes, et al.
Blood|July 9, 2004
Protease inhibitors potentiate chemotherapy-induced neutropeniaMark Bower, Neil McCall-Peat, Natalie Ryan, et al.
British Journal of Clinical Pharmacology|October 15, 2025
Beyond GLP-1s: The blueprint for systemic therapeutics that will reshape aging and medicineCarina C Kern, Annalisa Jenkins, D Nageshwar Reddy, et al.
The Journal of Antimicrobial Chemotherapy|December 21, 2004
A randomized study comparing a three- and four-drug HAART regimen in first-line therapy (QUAD study)Chloe Orkin, Justin Stebbing, Mark Nelson, et al.
Epigenomics|July 31, 2013
The p53 miRNA interactome and its potential role in the cancer clinicJonathan Krell, Adam E Frampton, Teresa Colombo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 11, 2009
Cryptogenic pseudocirrhosis: a new clinical syndrome of noncirrhotic portal hypertension (unassociated with advanced fibrosis) that can be detected by transient elastography in patients with HIVGeorge Panos, Lavanta Farouk, Justin Stebbing, et al.
JAMA Surgery|March 7, 2014
Reduced dissemination of circulating tumor cells with no-touch isolation surgical technique in patients with pancreatic cancerTamara M H Gall, Jimmy Jacob, Adam E Frampton, et al.
Pageof 51